BDTX vs LRCX · $95.7M cap vs P/E 71, rev $23.23B
Black Diamond Therapeutics Inc (BDTX) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported BDTX revenue for 2026-06-30 was $0. Net income was -$18.9M. BDTX currently screens at market cap $95.7M.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
BDTX currently screens at market cap $95.7M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the BDTX and LRCX stock pages for the full models.
Not investment advice.